Clinical Trials Logo

Astigmatism clinical trials

View clinical trials related to Astigmatism.

Filter by:

NCT ID: NCT06052046 Recruiting - Astigmatism Clinical Trials

Total30 for Astigmatism Contact Lenses

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

Determine if Total30 for Astigmatism contact lenses (CLs) provide a comfortable wearing experience all day. CL discomfort affects most CL wearers with discomfort consistently topping the reasons why established CL wearers drop out of CLs. In fact, studies have consistently found that the frequency of CL dropout is around 20% with this dropout frequency staying relatively stable over the past 20 plus years. This static frequency of CL dropout is surprising since there have been a number of dramatic soft CL innovations during this time frame (e.g., widely available daily disposable CLs, silicone hydrogel CL materials with high oxygen transmissibility, new CL surface coatings).

NCT ID: NCT05984290 Recruiting - Astigmatism Clinical Trials

Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens

Start date: July 11, 2023
Phase: N/A
Study type: Interventional

The objective of this orthokeratology study is to evaluate the safety and effectiveness of the Arise Orthokeratology Lens with non-spherical posterior peripheral curves

NCT ID: NCT05796453 Recruiting - Presbyopia Clinical Trials

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Start date: September 19, 2023
Phase: N/A
Study type: Interventional

The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.

NCT ID: NCT05670626 Recruiting - Myopia Clinical Trials

Correlation Between Preoperative Refraction and Anterior Segment Parameters With ICL Vault

Start date: December 14, 2022
Phase: N/A
Study type: Interventional

This prospective non-comparative interventional study aims to analyse the pre-operative factors affecting the range of optimal ICL vaulting. the main question is what is the correlation between age, gender, spherical equivalent, white to white, anterior chamber volume and depth and postoperative vault? participants will do preoperative investigations ( specular microscopy, pentacam and biometry ) then refractive surgery (ICL implantation) followed by follow-up visits to assess the post-operative ICL vault and visual outcome.

NCT ID: NCT05629078 Recruiting - Clinical trials for Astigmatism Bilateral

Vision and Balance Changes After Bilateral Implantation of Toric IOLs

Start date: January 12, 2024
Phase: N/A
Study type: Interventional

Cataracts are the major cause of blindness in the world. Cataract surgery, being the most performed surgery in the world today, provide correction by extracting the natural lens from its capsular bag and replaced by an artificial intraocular lens (IOL) implantation. In the UK, almost all patients undergoing cataract surgery by the NHS are given monofocal intraocular lenses (IOLs) which do not correct corneal astigmatic error. It is estimated that around 20% of the population has over 1.50DC of corneal astigmatism. Uncorrected astigmatism not only increase spectacle dependency and reduce quality of life post surgically, but it also adversely affects the overall economic costs. Specialised toric IOLs offer the opportunity to correct pre-existing corneal astigmatism. Previous work has shown a link between reduced vision and balance or mobility. Full correction of refractive error may have greater impact on lifestyle than previously thought.

NCT ID: NCT05611294 Recruiting - Myopia Clinical Trials

Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction

Start date: September 27, 2022
Phase: N/A
Study type: Interventional

This study evaluates differences in postoperative visual outcomes between patients receiving Topography-Guided LASIK in one eye and Small Incision Lenticule Extraction in the other eye.

NCT ID: NCT05596682 Recruiting - Presbyopia Clinical Trials

Prospective Multicenter Clinical Study on the Visual and Refractive Outcomes and Safety Outcomes Following Implantation of an AddOn Intraocular Lens in Previously Pseudophakic Eyes

Start date: October 17, 2022
Phase:
Study type: Observational

The purpose of this prospective multicenter clinical study is to evaluate the visual and refractive outcomes and safety outcomes following bilateral implantation of trifocal and/or trifocal toric 1stQ AddOn (Medicontur) intraocular lenses (IOLs) to correct residual refractive errors, astigmatism, and presbyopia in previously pseudophakic eyes.

NCT ID: NCT05574270 Recruiting - Cataract Clinical Trials

Clinical Investigation of a Small Aperture Extended Depth of Focus Intraocular Lens in Patients With Complex Corneas

Start date: July 12, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the clinical outcomes of the IC-8 IOL implanted in patients with complex corneas after crystalline lens removal.

NCT ID: NCT05486546 Recruiting - Myopia Clinical Trials

Contoura With Phorcides Compared to Wavefront Optimized LASIK

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

NCT ID: NCT05264623 Recruiting - Hyperopia Clinical Trials

Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

This will be a multicenter, prospective, open label, non-randomized, single arm 12 month study, evaluating the safety and effectiveness of the TECHNOLAS TENEO 317 Model 2 (Software version "1.28 US") excimer laser when used in LASIK surgery to treat hyperopia with or without hyperopic astigmatism. Both eyes of a subject may be enrolled so long as both eyes meet all inclusion/exclusion requirements. Analysis of the primary effectiveness endpoint will be completed at refractive stability.